Indoleamine 2,3-dioxygenase in infection: the paradox of an evasive strategy that benefits the host
- 31 January 2009
- journal article
- review article
- Published by Elsevier BV in Microbes and Infection
- Vol. 11 (1), 133-141
- https://doi.org/10.1016/j.micinf.2008.10.007
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- HIV-Induced Type I Interferon and Tryptophan Catabolism Drive T Cell Dysfunction Despite Phenotypic ActivationPLOS ONE, 2008
- Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammationProceedings of the National Academy of Sciences, 2008
- Role of Tryptophan supplementation in the treatment of ChlamydiaMedical Hypotheses, 2007
- Evolution of Vertebrate Indoleamine 2,3-DioxygenasesJournal of Molecular Evolution, 2007
- Severe Tryptophan Starvation Blocks Onset of Conventional Persistence and Reduces Reactivation of Chlamydia trachomatisInfection and Immunity, 2007
- Chronic innate immune activation as a cause of HIV-1 immunopathogenesisClinical Immunology, 2007
- Indoleamine 2,3-dioxygenase and tumor-induced toleranceJCI Insight, 2007
- Upregulation of Indoleamine 2,3-Dioxygenase in Hepatitis C Virus InfectionJournal of Virology, 2007
- Treatment of Autoimmune Neuroinflammation with a Synthetic Tryptophan MetaboliteScience, 2005
- Immunity to fungal infectionsNature Reviews Immunology, 2004